Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026)
Ascendis Pharma A (ASND) reported Exchange Rate Effect of $9.5 million for Q1 2026, up 204.89% on a YoY basis from $3.1 million in Q1 2025, and up 1759.71% sequentially from -$570381.3 in Q4 2025.
Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of Exchange Rate Effect data on file, last reported at $9.5 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 204.89% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 168.81% YoY), and the FY2025 full-year result was -$29.4 million, down 219.22% from the prior year.
- Exchange Rate Effect grew to $9.5 million in Q1 2026, from -$570381.3 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $9.5 million in Q1 2026 to a low of -$9.0 million in Q1 2025.
- A 5-year average of -$200866.6 and a median of -$570381.3 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 9903.63% in 2025 and jumped 204.89% in 2026, its largest moves.
- Tracing ASND's Exchange Rate Effect over 5 years: stood at $2.3 million in 2022, then plunged by 171.45% to -$1.6 million in 2023, then surged by 155.03% to $886934.2 in 2024, then plunged by 164.31% to -$570381.3 in 2025, then soared by 1759.71% to $9.5 million in 2026.
- Business Quant data shows ASND's Exchange Rate Effect at $9.5 million in Q1 2026, -$570381.3 in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 9.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.47 Mn |
| Mar 31, 2026 | 9.47 Mn |
| Dec 31, 2025 | -570,381.32 |
| Dec 31, 2025 | -570,381.32 |
| Sep 30, 2025 | -1.84 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -9.03 Mn |
| Mar 31, 2025 | -9.03 Mn |
| Dec 31, 2024 | 886,934.18 |
| Dec 31, 2024 | 886,934.18 |
| Sep 30, 2024 | 169,125.80 |
| Sep 30, 2024 | 169,125.80 |
| Jun 30, 2024 | 16,153.31 |
| Jun 30, 2024 | 16,153.31 |
| Mar 31, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Dec 31, 2023 | -1.61 Mn |